Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sri Navaratnam"'
Autor:
Rebekah Rittberg, Anmol Mann, Danielle Desautels, Craig C. Earle, Sri Navaratnam, Marshall Pitz
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 233-251 (2020)
Background: COVID-19 has spread rapidly, requiring health delivery systems to undertake dramatic transformations. To evaluate these system changes, we undertook one of the first Canadian health delivery system reviews and the first Canadian cancer ce
Externí odkaz:
https://doaj.org/article/2f7ba119b8cb49039f8a0fc1afba9032
Autor:
Sri Navaratnam, Craig C. Earle, Anmol Mann, Rebekah Rittberg, Marshall Pitz, Danielle Desautels
Publikováno v:
Current Oncology
Volume 28
Issue 1
Pages 26-251
Current Oncology, Vol 28, Iss 26, Pp 233-251 (2021)
Volume 28
Issue 1
Pages 26-251
Current Oncology, Vol 28, Iss 26, Pp 233-251 (2021)
Background: COVID-19 has spread rapidly, requiring health delivery systems to undertake dramatic transformations. To evaluate these system changes, we undertook one of the first Canadian health delivery system reviews and the first Canadian cancer ce
Autor:
Alain A. Demers, Georgios P. Skliris, Leigh C. Murphy, Ketan Badiani, Sri Navaratnam, Shantanu Banerji, Gefei Qing, Dongsheng Tu, Janet Nowatzki, Natasha B. Leighl, Frances A. Shepherd, Penelope A. Bradbury
Publikováno v:
Hormones and Cancer. 3:93-100
Although women have an increased susceptibility to lung cancer, they also have a favorable clinical outcome. This may in part be due to female specific genetic and hormonal factors. In the present study, expression of ER-beta was investigated by immu
Autor:
Gokulan Sivananthan, Alain A. Demers, Sri Navaratnam, Grace Musto, James R.G. Butler, Erich V. Kliewer, Stephen Welch, Winson Y. Cheung
Publikováno v:
Lung Cancer. 72:125-131
Purpose: To determine the wait times and healthcare costs around the time of non-small cell lung cancer (NSCLC) diagnosis for a large, population-based cohort of patients. Methods: Data on baseline demographics, diagnostic and staging tests, timeline
Autor:
Ketan Badiani, Sri Navaratnam, Erich V. Kliewer, Alain A. Demers, Grace Musto, James R.G. Butler
Publikováno v:
Lung Cancer. 70:110-115
Background The aim of this study was to examine the patterns and costs of management of non-small cell lung cancer (NSCLC) after completion of chemotherapy until death in a population of patients in Manitoba, Canada. Patients and methods Stage IIIB a
Publikováno v:
Clinical Pulmonary Medicine. 14:281-285
We investigate the outcome of lung cancer patients admitted to the medical intensive care unit (MICU) and examine potential predictors of mortality. A retrospective quality assurance study of primary lung cancer patients admitted to the MICUs at 2 lo
Publikováno v:
Current Oncology
Volume 19
Issue 1
Pages 1012-42
Volume 19
Issue 1
Pages 1012-42
Original Citation Curr Oncol 2011;18(5): e238–42. Published online October 3, 2011. Author’s Description of Error Zoann Nugent is to be retracted from the author list. The correct author list and affiliations appear above.
Publikováno v:
Current Oncology
Volume 18
Issue 5
Pages 780-242
Volume 18
Issue 5
Pages 780-242
Lung cancer is the leading cause of cancer death worldwide. Non-small-cell lung cancer (nsclc) is the most common form of lung cancer, with a median age at diagnosis of 70 years. These elderly patients are often underrepresented in the randomized cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798495346ea1d576d7d2d0f8fffad35f
https://europepmc.org/articles/PMC3185905/
https://europepmc.org/articles/PMC3185905/
Autor:
Joel Gingerich, Leigh C. Murphy, Sri Navaratnam, Emilia Wiechec, Heinrich Baust, Marshall Pitz, Georgios P. Skliris, Jerry M. Maniate, James B. Johnston, Marek Los
Clinical studies have shown that HER-2/Neu is over-expressed in up to one-third of patients with a variety of cancers, including B-cell acute lymphoblastic leukemia (B-ALL), breast cancer and lung cancer, and that these patients are frequently resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd6c39b55fe3306a3daa3f7a641d6b3a
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-86994
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-86994
Autor:
Rajat Kumar, Bernie Lozar, Pamela Skrabek, James B. Johnston, Baptist Joseph, Kimi Guilbert, Venetia Bourrier, Patricia Burns, Sri Navaratnam
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 11:S283-S284